Yussef Bennani, MD
Infectious Disease · New Orleans, LANPI 1730478363
Payments from drug & device makers
What this record shows
That places this record below the midpoint for infectious disease clinicians in LA, where the typical reported total is $611.
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
Across 53 payments — averaging $3285.65 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gilead$151K
- Viiv Healthcare Company$23K
How this compares
$0 in reported general payments places this provider in the 5th percentile of 105 infectious disease providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 297 | $1,160,456 |
| TivicayDolutegravir Sodium | 203 | $498,928 |
| DescovyEmtricitabine/Tenofov Alafenam | 156 | $345,799 |
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 60 | $277,546 |
| GenvoyaElviteg/Cob/Emtri/Tenof Alafen | 37 | $140,563 |
| PrezcobixDarunavir/Cobicistat | 33 | $77,929 |
| JulucaDolutegravir/Rilpivirine | 22 | $75,358 |
| Darunavir | 48 | $33,393 |
| OzempicSemaglutide | 27 | $25,788 |
| JardianceEmpagliflozin | 26 | $15,583 |
| Etravirine | 13 | $11,090 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 21 | $10,376 |
| EliquisApixaban | 17 | $9,658 |
| Vancomycin Hcl | 29 | $8,900 |
| JanuviaSitagliptin Phosphate | 11 | $6,871 |
Paid to pharmacies, not to this prescriber.
Other infectious disease in New Orleans
- Eric EhrensingNew Orleans$97K
- Meredith ClementNew Orleans$93K
- Rebecca LillisNew Orleans$60K
- Stephanie TaylorNew Orleans$25K
- Edwin SwiatloNew Orleans$22K
- Jonathan HandNew Orleans$10K
- Markalain DeryNew Orleans$9K
- Julia Garcia-DiazNew Orleans$8K
- Obinna NneduNew Orleans$3K
- Katherine BaumgartenNew Orleans$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.